Infinity Pharma (INFI) Misses Q4 EPS by 8c, FY Revenue Guidance Tops Views
Go back to Infinity Pharma (INFI) Misses Q4 EPS by 8c, FY Revenue Guidance Tops Views| Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) | Delayed: 0.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.04 | 52 Week High | $8.98 | |||
| Open | $11.23 | 52 Week Low | $0.84 | |||
| Day High | $0.04 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $-3.42 | |||
| Volume | 87,833 | |||||
